Tandem mass spectrometry of globotriaosylceramide in plasma and urine: strategy for diagnosis and therapy monitoring in Fabry disease | Charles Explorer

Tandem mass spectrometry of globotriaosylceramide in plasma and urine: strategy for diagnosis and therapy monitoring in Fabry disease

Publication

Abstract

tandem mass spectrometry, globotriaosylceramide, ERT monitoring, Fabry disease

People